← Back to Clinical Trials
Recruiting NCT06184945

NCT06184945 Behavioral Economic & Staffing Strategies in the ICU

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06184945
Status Recruiting
Phase
Sponsor University of Nebraska
Condition Implementation Science
Study Type INTERVENTIONAL
Enrollment 8,100 participants
Start Date 2024-07-01
Primary Completion 2028-04

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Realtime audit and feedbackRN Implementation Facilitator

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 8,100 participants in total. It began in 2024-07-01 with a primary completion date of 2028-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overarching goal of this study is to support the "real world" assessment of strategies used to foster adoption of several highly efficacious evidence-based practices in healthcare systems that provide care to critically ill adults with known health disparities. Investigators will specifically evaluate two discrete strategies grounded in behavioral economic and implementation science theory (i.e., real-time audit and feedback and registered nurse implementation facilitation) to increase adoption of the ABCDEF bundle in critically ill adults.

Eligibility Criteria

Inclusion Criteria: * Age \>19 years at time of ICU admission * Received invasive mechanical ventilation while in the ICU * Admitted to participating cluster ICU * ICU length of stay of at least 24 hours Exclusion Criteria: * Patient who is admitted to the hospital who is already receiving chronic long-term mechanical ventilation from the home, assisted living, or long-term care setting * Prisoners

Contact & Investigator

Central Contact

Michele C Balas, PhD, RN

✉ mibalas@unmc.edu

📞 (614) 949-5555

Principal Investigator

Michele C Balas, PhD, RN

PRINCIPAL INVESTIGATOR

University of Nebraska

Frequently Asked Questions

Who can join the NCT06184945 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Implementation Science. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06184945 currently recruiting?

Yes, NCT06184945 is actively recruiting participants. Contact the research team at mibalas@unmc.edu for enrollment information.

Where is the NCT06184945 trial being conducted?

This trial is being conducted at Iowa City, United States, Omaha, United States, Columbus, United States.

Who is sponsoring the NCT06184945 clinical trial?

NCT06184945 is sponsored by University of Nebraska. The principal investigator is Michele C Balas, PhD, RN at University of Nebraska. The trial plans to enroll 8,100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology